回到主页

Epidemic Trend and Treatment

Diagnosis, Clinical Management, Medicines, Vaccines, Cases, and Models

Diagnosis, Clinical Management, and Control Measures of Covid-19

April, 1, 2020. Front line doctor in Wuhan talks to the medical team from Haifa, Israel.

As an infectious disease physician, Dr. Rongmeng Jiang, has been actively involved in the prevention and treatment of Covid-19 on the front line, city of Wuhan, since Jan 9, 2020. Through XIN's coordination, Dr. Jiang shared his experiences and observations during the meeting discussion with Dr. Roimi’s team from Rambam Health Care Campus, Haifa, Israel. As suggested by Dr. Jiang, in the absence of effective medicines and vaccines, the key is to break the chain of infection. The sharing is presented at this website

Investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China

Mar. 31, 2020. Science Magazine, Researchers from China, UK, and USA.

Responding to an outbreak of a novel coronavirus in December 2019, China banned travel to and from Wuhan city on 23 January and implemented a national emergency response. The research team studied the spread and control of Covid-19 using a unique data set including case reports, human movement and public health interventions.

COVID-19 Model: US State-by-state projections

Mar. 30, 2020. Institute for Health Metrics and Evaluation (IHME), University of Washington, USA

IHME’s COVID-19 model relies on the data from Italy, China and the United States, using past experiences to predict the future. The projections show demand for hospital services in each state.

Control COVID-19 transmission in Shanghai, a population of 24 million metropolis 

Mar. 24, 2020. Wenhong Zhang, Leader of the Shanghai Anti-COVID-19 Clinical Expert Team. CABS (Chinese-American Bio/Pharmaceutical Society) WEBINAR

Dr. Zhang introduces the first hand experiences on how to prevent Covid-19 transmission in Shanghai, a population of 24 million metropolis in China. The patients data in Shanghai are compared with Wuhan, and the experiences gained on diagnosis, prevention, treatment, and medical staff protection are also discussed. Some information are summarized at this website.

Impact of non-pharmaceutical interventions (NPI) to reduce COVID-19 mortality and healthcare demand

March 16, 2020. Neil M Ferguson, et al., Imperial College COVID-19 Response Team

The team presents the results of epidemiological modeling which ahs informed policymaking in the UK and other countries in recent weeks. The conclusion is that the effectiveness of any one intervention in isolation is likely to be limited, requiring multiple interventions to be combined to have substantial impact on transmission.

Report of the WHO-China joint mission on Coronavirus Disease 2019 (COVID-2019)

Feb. 16-24, 2020. Bruce Aylward, et al., WHO-China Joint Mission Members.

The overall goal was to rapidly inform national (China) and international planning on next steps in the response to the ongoing outbreak of the novel coronavirus (COVID-19) and on next steps in readiness and preparedness for geographic areas not yet affected. There were 55,924 laboratory confirmed cases reported as of Feb. 20, 2020. The main findings are described in six sections: the virus, the outbreak, transmission dynamics, disease progression and severity, the China response and knowledge gaps.

所有文章
×

还剩一步!

确认邮件已发至你的邮箱。 请点击邮件中的确认链接,完成订阅。

好的